Characteristically, CLL/SLL features expression of variably decreased CD20, CD5, decreased CD81, CD23, CD43, bright CD200, dim to absent FMC7, and mono- or bi-clonal, dim or negative surface immunoglobulin expression [14]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.